Opioid and Other Substance Use Disorders Study Committee Final Report
The Interim Committee on Opiod and other Substance Use Disorders was created pursuant to Section 10-22.3-101.
Second Regular Session | 74th General Assembly
Colorado General AssemblyThe Interim Committee on Opiod and other Substance Use Disorders was created pursuant to Section 10-22.3-101.
The Colorado Health Insurance Exchange Oversight Committee was created pursuant to Article 22 of Title 10, Colorado Revised Statutes. The purpose of this committee is to guide Colorado's health insurance exchange, including reviewing the financial and operational plans of the exchange and...
Final Report to the Colorado General Assembly by the Legislative Oversight Committee Concerning the Treatment of Persons with Mental Health Disorders in the Criminal and Juvenile Justice Systems.
During the 2017 legislative session, the General Assembly considered numerous measures on child welfare, domestic violence and crimes against children, the juvenile justice system, public school safety, and child care. The bills described in this document passed and became law, unless otherwise...
During the 2017 legislative session, the General Assembly considered several measures related to Medicaid, insurance carriers, and substance use disorder in Colorado. The General Assembly also considered measures related to background checks for some types of providers and made changes to the...
Final Report to the Colorado General Assembly by the Opioid and Other Substance Use Disorders Interim Study Committee.
During the 2017 legislative session, the General Assembly considered measures related to Colorado’s behavioral health crisis system and the use and misuse of opioids. Other issues considered include child care regulations, child welfare, and a job program for individuals receiving cash...
Presented to the TLRC at its November 2, 2017 meeting.
This memorandum addresses patient access to experimental treatments, including access to clinical trials, participation in the U.S. Food and Drug Administration’s Expanded Access (Compassionate Use) Program, and access to treatments under Colorado’s Right to Try Act. Additionally, this...
The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details